EGFR and small cell lung carcinoma: These reports, together with the current study that observed a reciprocal relationship between SCLC transformation and EGFR T790M mutation, indicate that we have to keep the possibility of inter-tumour heterogeneity of resistance mechanisms in mind when treating patients using resistance mechanism-specific therapies based on the molecular analysis of biopsied small samples.